Back
Legend Biotech Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
30
LEGN
Legend Biotech
Last Price:
51.55
Seasonality Move:
9.49%
Sell
50
BMRN
Biomarin Pharmaceutical
Last Price:
70.46
Seasonality Move:
2.96%
Sell
30
Legend Biotech (LEGN)
is a Sell
Is Legend Biotech a Buy, Sell or Hold?
- The current Legend Biotech [LEGN] share price is $50.31. The Score for LEGN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- LEGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $84.90. The Score for BMRN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LEGN Stock Price Chart
What is Legend Biotech's stock price today?
-
The Legend Biotech share price today is $50.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEGN is experiencing selling pressure, which indicates risk of future bearish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $84.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
LEGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.35 | Sell |
Relative Strength Index (14 RSI): | 37.7 | Sell |
Chaikin Money Flow: | -271494 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.98 - 57.98) | Sell |
Bollinger Bands (100): | (43.22 - 55.54) | Buy |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.8 | Sell |
Relative Strength Index (14 RSI): | 40.73 | Sell |
Chaikin Money Flow: | 962873 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.01 - 91.87) | Sell |
Bollinger Bands (100): | (79.53 - 88.41) | Buy |
LEGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.33 | Sell |
20-day SMA: | 54.74 | Sell |
50-day SMA: | 54.82 | Sell |
200-day SMA: | 54.28 | Sell |
8-day EMA: | 51.48 | Sell |
20-day EMA: | 53.45 | Sell |
50-day EMA: | 53.37 | Sell |
200-day EMA: | 54.23 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.29 | Sell |
20-day SMA: | 88.8 | Sell |
50-day SMA: | 86.64 | Sell |
200-day SMA: | 87.31 | Sell |
8-day EMA: | 85.7 | Sell |
20-day EMA: | 87.17 | Sell |
50-day EMA: | 86.68 | Sell |
200-day EMA: | 86.64 | Sell |
Legend Biotech Earnings Growth & LEGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.19 per share, an increase this year of $1.77 per share, and an increase next year of $0.54 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Legend Biotech Technical Analysis
Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |